Home Cart 0 Sign in  
X

[ CAS No. 163444-17-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 163444-17-5
Chemical Structure| 163444-17-5
Chemical Structure| 163444-17-5
Structure of 163444-17-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 163444-17-5 ]

Related Doc. of [ 163444-17-5 ]

Alternatived Products of [ 163444-17-5 ]

Product Details of [ 163444-17-5 ]

CAS No. :163444-17-5 MDL No. :MFCD02683097
Formula : C7H5F3IN Boiling Point : -
Linear Structure Formula :- InChI Key :UKKWTZPXYIYONW-UHFFFAOYSA-N
M.W : 287.02 Pubchem ID :2783322
Synonyms :

Calculated chemistry of [ 163444-17-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 48.57
TPSA : 26.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.88
Log Po/w (XLOGP3) : 2.78
Log Po/w (WLOGP) : 4.05
Log Po/w (MLOGP) : 3.44
Log Po/w (SILICOS-IT) : 3.1
Consensus Log Po/w : 3.05

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.67
Solubility : 0.0607 mg/ml ; 0.000211 mol/l
Class : Soluble
Log S (Ali) : -2.98
Solubility : 0.299 mg/ml ; 0.00104 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.87
Solubility : 0.0388 mg/ml ; 0.000135 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.55

Safety of [ 163444-17-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 163444-17-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 163444-17-5 ]
  • Downstream synthetic route of [ 163444-17-5 ]

[ 163444-17-5 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 544-92-3 ]
  • [ 163444-17-5 ]
  • [ 6526-08-5 ]
Reference: [1] Patent: WO2007/41494, 2007, A2, . Location in patent: Page/Page column 34
[2] Patent: WO2007/81570, 2007, A2, . Location in patent: Page/Page column 30
[3] Patent: WO2005/100298, 2005, A1, . Location in patent: Page/Page column 44
[4] Patent: WO2006/14357, 2006, A1, . Location in patent: Page/Page column 36
[5] Patent: WO2007/79186, 2007, A2, . Location in patent: Page/Page column 39
  • 2
  • [ 163444-17-5 ]
  • [ 6526-08-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 24, p. 7469 - 7472
[2] ACS Medicinal Chemistry Letters, 2011, vol. 2, # 6, p. 424 - 427
[3] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4880 - 4895
[4] Organic Letters, 2018, vol. 20, # 2, p. 345 - 348
  • 3
  • [ 163444-17-5 ]
  • [ 75-05-8 ]
  • [ 6526-08-5 ]
Reference: [1] Synlett, 2012, vol. 23, # 17, p. 2491 - 2496,6
  • 4
  • [ 163444-17-5 ]
  • [ 6526-08-5 ]
Reference: [1] Synlett, 2006, # 1, p. 65 - 68
  • 5
  • [ 455-14-1 ]
  • [ 163444-17-5 ]
YieldReaction ConditionsOperation in experiment
97% With Iodine monochloride In methanol; dichloromethane at 0 - 20℃; Step 2
2-Iodo-4-(trifluoromethyl)aniline
A 500 mL 3-necked round bottom flask was charged with 4-(trifluoromethyl)aniline (22.5 g, 0.14 mol) and MeOH (100 mL).
To the above was added dropwise a solution of IC1 (25 g, 0.15 mol) in CH2Cl2 (100 mL) at 0° C.
The resulting mixture was stirred at room temperature for 1 h.
Reaction progress was monitored by TLC (EtOAc/Petroleum ether=1:10, Rf=0.5). Work-up:
the mixture was concentrated in vacuo.
The residue was re-dissolved in CH2Cl2, washed with water, dried over anhydrous Na2SO4 and concentrated in vacuo, to give 37.8 g (97percent) of the product. 1H NMR (300 MHz, CDCl3) δ: 7.86 (d, J=1.2 Hz, 1H), 7.36 (dd, J=8.4, 1.8 Hz, 1H), 6.73 (d, J=8.7 Hz, 1H), 4.41 (br, 2H).
97% With Iodine monochloride In methanol; dichloromethane at 0 - 20℃; for 1 h; A 500 mL 3-necked round bottom flask was charged with 4- (trifluoromethyl)aniline (22.5 g, 0.14 mol) and MeOH (100 mL). To the above was added dropwise a solution of ICl (25 g, 0.15 mol) in CH2C12 (100 mL) at 0 °C. The resulting mixture was stirred at room temperature for 1 h. Reaction progress was monitored by TLC (EtO Ac/Petroleum ether = 1 : 10, Rf = 0.5). Work-up: the mixture was concentrated in vacuo. The residue was re-dissolved in CH2C12, washed with water, dried over anhydrous Na2S04 and concentrated in vacuo, to give 37.8 g (97percent) of the product. *H NMR (300 MHz, CDC13) δ: 7.86 (d, J = 1.2 Hz, 1H), 7.36 (dd, J = 8.4, 1.8 Hz, 1H), 6.73 (d, J = 8.7 Hz, 1H), 4.41 (br, 2H).
89% With N-iodo-succinimide; [bis(trifluoromethanesulfonyl)imidate](triphenylphosphine)gold(I) In 1,2-dichloro-ethane; toluene at 85℃; for 14 h; General procedure: To a stirred solution of the substrate (1 mmol) in CH2Cl2 or (CH2Cl)2 (0.1 M) were added Ph3PAuNTf2 (0.025 mmol, 19 mg; complex Ph3PAuNTf2 toluene, 2:1) followed by N-iodosuccinimide (1.1 mmol, 248 mg). The resulting solution was stirred at r.t. or under reflux until complete conversion of the starting material. After removal of the solvent under reduced pressure, the crude material was purified by flash column chromatography using different gradients of hexanes and EtOAc to obtain the pure desired products.
75% With N,N,N-trimethylbenzenemethanaminium dichloroiodate; calcium carbonate In methanol; dichloromethane at 20℃; for 24 h; PREPARATION 4; 2-Iodo-4-(trifluoromethyl)aniline; A solution of 5 g (31 mM) of 4-(trifluoromethyl)aniline in 90 ml of methanol and 30 ml of dichloromethane is prepared and 3.56 g (35.6 mM) of calcium carbonate are added. 14.9 g (42.7 mM) of trimethylbenzylammonium dichloroiodide are then added in portions at room temperature, with stirring. The reaction medium is stirred for 24 hours at room temperature and then filtered to remove the mineral salts. The filtrate is concentrated under reduced pressure and the crude product is purified by chromatography on silica gel using a cyclohexane/ethyl acetate mixture (8/2; v/v) as the eluent to give 6.65 g of the expected compound in the form of an orange oil (yield=75percent).1H NMR (CDCl3, 300 MHz) δ=5.0 (s, 2H), 6.82 (d, J=5.5 Hz, 1H), 7.38 (dd, J=5.5 Hz, 1.3 Hz, 1H), 7.79 (d, J=1.3 Hz, 1H).
70% With Iodine monochloride In methanol; dichloromethane at 20℃; To a solution of 4-(trifluoromethyl)benzenamine (10.0 g, 0.0617 mol) in dry methanol (200 ml) was added iodine monochloride (10.49 g, 0.148 mol) in dry MDC (40 ml) at RT slowly. Reaction mixture was stirred at RT over night. The reaction mixture was concentrated, water was added and extracted with ethyl acetate (2.x.100 ml). The organic layer was washed with water, brine (2.x.50 ml), dried over Na2SO4 and concentrated. The crude product was purified by column chromatography using 6percent ethyl acetate in pet-ether to get 2-iodo-4-(trifluoromethyl)benzenamine (12.5 g, 70percent) as pale yellow liquid. 1H NMR (400 MHz, CDCl3) δ 4.42 (bs, 2H), 6.75 (d, 1H), 7.38 (d, 1H), 7.87 (s, 1H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; Method DSynthesis of substituted 2-(1 H-indol-3-yl)ethanamineStep I: substituted 2-iodo-aniline Iodine (1 eq) was added to a stirred mixture of silver sulphate (1 eq) and an aniline (1 eql) in ethanol (6.21 mL/mmol). The reaction mixture was then stirred at room temperature for 18 hours and filtered over celite. The solution was concentrated under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulphate. The organic layer was washed with brine, dried with magnesium sulphate and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel to yield a substituted 2-iodo-aniline; INTERMEDIATE 10 - PREPARATION of 2-iodo-4-(trifluoromethyl)aniline. 2-iodo-4-(trifluoromethyl)aniline was prepared according to method D Step I with iodine (1.58 g; 6.21 mmol), silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 mL; 6.21 mmol) in ethanol (40 mL). The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40 percent ethyl acetate in heptane) to afford 1.08 g (61 percent) of 2-iodo-4-(trifluoromethyl)aniline as a red oil.1 H NMR (DMSO-d6) δ 7.80 (s, 1 H), 7.38 (d, 1 H), 6.82 (d, 2H), 5.93 (s, 2H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; INTERMEDIATE 40 - PREPARATION of 2-lodo-4-(trifluoromethyl)aniline. Iodine (1.58 g; 6.21 mmol) was added to a stirred mixture of silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 mL; 6.21 mmol) in ethanol (40 mL). The reaction mixture was then stirred at room temperature for 18 hours and filtered over celite. The volatiles were removed under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulfate. The organic layer was washed with brine, dried and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40 percent ethyl acetate in heptane) to afford 1.08 g (61 percent) of the title compound as a red oil.1 H NMR (DMSO-d6) δ 7.80 (s, 1 H), 7.38 (d, 1 H), 6.82 (d, 2H), 5.93 (s, 2H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; Iodine (1.58 g; 6.21 mmol) was added to a stirred mixture of silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 mL; 6.21 mmol) in ethanol (40 mL). The reaction mixture was then stirred at room temperature for 18 hours and filtered over celite. The volatiles were removed under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulfate. The organic layer was washed with brine, dried and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40percent ethyl acetate in heptane) to afford 1.08 g (61percent) of the title compound as a red oil. [0628] 1H NMR (DMSO-d6) δ 7.80 (s, 1H), 7.38 (d, 1H), 6.82 (d, 2H), 5.93 (s, 2H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; Iodine (1 eq) was added to a stirred mixture of silver sulphate (1 eq) and an aniline (1 eql) in ethanol (6.21 mL/mmol). The reaction mixture was then stirred at room temperature for 18 hours and filtered over celite. The solution was concentrated under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulphate. The organic layer was washed with brine, dried with magnesium sulphate and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel to yield a substituted 2-iodo-aniline. 2-iodo-4-(trifluoromethyl)aniline was prepared according to method D Step I with iodine (1.58 g; 6.21 mmol), silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 mL; 6.21 mmol) in ethanol (40 mL). The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40percent ethyl acetate in heptane) to afford 1.08 g (61percent) of 2-iodo-4-(trifluoromethyl)aniline as a red oil. [0533] 1H NMR (DMSO-d6) δ 7.80 (s, 1H), 7.38 (d, 1H), 6.82 (d, 2H), 5.93 (s, 2H).
61% With iodine; silver sulfate In ethanol at 20℃; for 18 h; INTERMEDIATE 132 - PREPARATION of 2-iodo-4-(trifluoromethyl)aniline; Iodine (1.58 g; 6.21 mmol) was added to a stirred mixture of silver sulphate (1.94 g; 6.21 mmol) and 4-(trifluoromethyl)aniline (0.8 ml
6.21 mmol) in ethanol (40 ml_). The reaction mixture was then stirred at room temperature for 18 hours and filtered through celite. The volatiles were removed under reduced pressure and the residue was partitioned between ethyl acetate and a saturated aqueous solution of sodium thiosulphate. The organic layer was washed with brine, dried and concentrated under reduced pressure. The crude residue was purified by flash chromatography on silica gel (eluent 2 to 40 percent ethyl acetate in heptane) to afford 1.08 g (61 percent) of 2-iodo-4-(trifluoromethyl)aniline as a red oil. 1H NMR (DMSO-de) δ 7.80 (s, 1 H), 7.38 (d, 1 H), 6.82 (d, 2H), 5.93 (s, 2H)
2.3 g With iodine; silver sulfate In ethanol at 20℃; for 1 h; A mixture of 2.5 g of 4-trifluoromethylaniline, 3.9 g of iodine, 4.8 g of silver (I) sulfate, and 300 ml of ethanol was stirred for 1 hour at room temperature. The reaction mixture was filtered through celite, and the filtrate was concentrated under reduced pressure. The residues were subjected to silica gel column chromatography, thereby obtaining 2.3 g of 2-iodo-4-trifluoromethylaniline.1H-NMR (CDC13) ö: 7.88-7.85 (m, 1H), 7.40-7.35 (m, 1H), 6.74 (d, 1H, J=8.3 Hz), 4.42 (br s, 2H)

Reference: [1] Heterocycles, 2002, vol. 57, # 3, p. 465 - 476
[2] Patent: US2010/120741, 2010, A1, . Location in patent: Page/Page column 91
[3] Patent: WO2011/112731, 2011, A2, . Location in patent: Page/Page column 196
[4] Synthesis, 2004, # 11, p. 1869 - 1873
[5] Synlett, 2014, vol. 25, # 3, p. 399 - 402
[6] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 9, p. 2722 - 2725
[7] Patent: US2008/153816, 2008, A1, . Location in patent: Page/Page column 7
[8] Organic Letters, 2011, vol. 13, # 12, p. 3242 - 3245
[9] Patent: US2005/54626, 2005, A1, . Location in patent: Page/Page column 34
[10] Tetrahedron, 1994, vol. 50, # 25, p. 7343 - 7366
[11] Patent: WO2012/80220, 2012, A1, . Location in patent: Page/Page column 71; 75
[12] Patent: WO2012/80221, 2012, A1, . Location in patent: Page/Page column 84-85
[13] Patent: US2013/274260, 2013, A1, . Location in patent: Paragraph 0627-0628
[14] Patent: US2013/289033, 2013, A1, . Location in patent: Paragraph 0510; 0532-0533
[15] Patent: WO2010/142801, 2010, A1, . Location in patent: Page/Page column 187
[16] Arzneimittel-Forschung/Drug Research, 2000, vol. 50, # 12, p. 1084 - 1092
[17] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4385 - 4388
[18] Organic Letters, 2005, vol. 7, # 10, p. 2043 - 2046
[19] Synlett, 2006, # 1, p. 65 - 68
[20] Journal of Organic Chemistry, 2006, vol. 71, # 18, p. 7079 - 7082
[21] Journal of Organic Chemistry, 2009, vol. 74, # 17, p. 6631 - 6636
[22] Patent: WO2005/13985, 2005, A1, . Location in patent: Page/Page column 47-49
[23] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 5, p. 1351 - 1357
[24] Patent: US2015/289512, 2015, A1, . Location in patent: Paragraph 1208; 1209
[25] Journal of Organic Chemistry, 2016, vol. 81, # 22, p. 10987 - 10999
  • 6
  • [ 16499-53-9 ]
  • [ 163444-17-5 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 16, p. 4234 - 4237
  • 7
  • [ 878133-04-1 ]
  • [ 163444-17-5 ]
Reference: [1] Synlett, 2006, # 1, p. 65 - 68
  • 8
  • [ 402-14-2 ]
  • [ 163444-17-5 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 16, p. 4234 - 4237
  • 9
  • [ 455-14-1 ]
  • [ 163444-17-5 ]
  • [ 214400-66-5 ]
Reference: [1] Arzneimittel-Forschung/Drug Research, 2000, vol. 50, # 12, p. 1084 - 1092
  • 10
  • [ 163444-17-5 ]
  • [ 100846-24-0 ]
Reference: [1] Heterocycles, 2002, vol. 57, # 3, p. 465 - 476
[2] Heterocycles, 2002, vol. 57, # 3, p. 465 - 476
  • 11
  • [ 127-17-3 ]
  • [ 163444-17-5 ]
  • [ 496946-78-2 ]
YieldReaction ConditionsOperation in experiment
65% With 1,4-diaza-bicyclo[2.2.2]octane; palladium diacetate In N,N-dimethyl-formamide at 105℃; for 10 h; Inert atmosphere A mixture of 2-iodo-4-(trifluoromethyl)aniline (C34) (250 mg, 0.871 mmol), pyruvic acid (0.123 mL,1.74 mmol), (195 mg, 1.74 mmol), and palladium(ll) acetate (10 mg, 44 pmol) in dry N,N-dimethylformamide (10 mL) was degassed viavacuum / nitrogen purges and heated at 105 °C for 10 h. The reaction mixture was allowed to cool to room temperature and was partitioned between ethyl acetate and water. The organic layer was washed with brine, dried over sodium sulfate, and concentrated under vacuum. The residue was purified by silica gel chromatography, eluting with 10percent ethyl acetate in hexane, to give the title compound as a brown solid.Yield: 130 mg, 65percent. LCMS m/z 228.0 (M-H); 1H NMR (400 MHz, DMSO-d6) ö 13.27 (5,1H), 12.20 (5, 1H), 8.09 (5, 1H), 7.61 (d, J=8.7 Hz, 1H), 7.51 (d, J=8.6 Hz, 1H), 7.25 (5,1 H).
1.15 g With 1,4-diaza-bicyclo[2.2.2]octane; palladium diacetate In N,N-dimethyl-formamide at 100℃; for 24 h; Inert atmosphere A mixture of 2.28 g of 2-iodo-4-trifluoromethyla- niline, 2.10 g of pyruvic acid, 2.67 g of DAI3CO, 89mg of palladium (II) acetate, and 25 ml of DMF was stirred for 24 hours at 1000 C. in nitrogen atmosphere. After the reaction mixture was cooled to room temperature, 25 ml of ethyl acetate and 50 ml of 5 M hydrochloric acid were added thereto, and extraction was performed three times by using ethyl acetate. The collected organic layer was washed with water and saturated saline, dried over magnesium sulfate, and then concentrated under reduced pressure. The residues were washed with chloroform, thereby obtaining 1.15 g of 5-trif- luoromethylindole-2-carboxylic acid (hereinafter, described as a “compound 7 of the present invention”).1H-NMR (DMSO-D5) ö: 13.24 (br s, 1H), 12.20 (br s, 1H), 8.08 (s, 1H), 7.60 (d, 1H, J=8.8 Hz), 7.51 (dd, 1H, J8.8, 1.6 Hz), 7.24 (d, 1H, J=1.6 Hz)
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 9, p. 2722 - 2725
[2] Patent: WO2015/49616, 2015, A1, . Location in patent: Page/Page column 66; 67
[3] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 24, p. 4385 - 4388
[4] Patent: US2007/88071, 2007, A1, . Location in patent: Page/Page column 16
[5] Patent: US2015/289512, 2015, A1, . Location in patent: Paragraph 1210; 1211
  • 12
  • [ 163444-17-5 ]
  • [ 852203-17-9 ]
Reference: [1] Synlett, 2006, # 1, p. 65 - 68
  • 13
  • [ 67-56-1 ]
  • [ 201230-82-2 ]
  • [ 163444-17-5 ]
  • [ 117324-58-0 ]
Reference: [1] Patent: EP1736465, 2006, A1, . Location in patent: Page/Page column 34
  • 14
  • [ 163444-17-5 ]
  • [ 702641-04-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4880 - 4895
[2] Organic Letters, 2018, vol. 20, # 2, p. 345 - 348
[3] Patent: WO2007/79186, 2007, A2,
  • 15
  • [ 163444-17-5 ]
  • [ 702641-06-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 13, p. 4880 - 4895
[2] Patent: WO2007/79186, 2007, A2,
  • 16
  • [ 68-12-2 ]
  • [ 163444-17-5 ]
  • [ 898748-27-1 ]
Reference: [1] RSC Advances, 2014, vol. 4, # 12, p. 6090 - 6093
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 163444-17-5 ]

Fluorinated Building Blocks

Chemical Structure| 97760-97-9

[ 97760-97-9 ]

2-Amino-5-iodobenzotrifluoride

Similarity: 0.91

Chemical Structure| 105202-02-6

[ 105202-02-6 ]

2-Iodo-5-(trifluoromethyl)aniline

Similarity: 0.89

Chemical Structure| 875306-20-0

[ 875306-20-0 ]

2-Bromo-6-iodo-4-(trifluoromethyl)aniline

Similarity: 0.81

Chemical Structure| 328-73-4

[ 328-73-4 ]

1-Iodo-3,5-bis(trifluoromethyl)benzene

Similarity: 0.75

Chemical Structure| 401-81-0

[ 401-81-0 ]

1-Iodo-3-(trifluoromethyl)benzene

Similarity: 0.75

Aryls

Chemical Structure| 97760-97-9

[ 97760-97-9 ]

2-Amino-5-iodobenzotrifluoride

Similarity: 0.91

Chemical Structure| 105202-02-6

[ 105202-02-6 ]

2-Iodo-5-(trifluoromethyl)aniline

Similarity: 0.89

Chemical Structure| 875306-20-0

[ 875306-20-0 ]

2-Bromo-6-iodo-4-(trifluoromethyl)aniline

Similarity: 0.81

Chemical Structure| 455-13-0

[ 455-13-0 ]

4-Iodobenzotrifluoride

Similarity: 0.75

Chemical Structure| 328-73-4

[ 328-73-4 ]

1-Iodo-3,5-bis(trifluoromethyl)benzene

Similarity: 0.75

Amines

Chemical Structure| 97760-97-9

[ 97760-97-9 ]

2-Amino-5-iodobenzotrifluoride

Similarity: 0.91

Chemical Structure| 105202-02-6

[ 105202-02-6 ]

2-Iodo-5-(trifluoromethyl)aniline

Similarity: 0.89

Chemical Structure| 875306-20-0

[ 875306-20-0 ]

2-Bromo-6-iodo-4-(trifluoromethyl)aniline

Similarity: 0.81

Chemical Structure| 29289-13-2

[ 29289-13-2 ]

2-Iodo-4-methylaniline

Similarity: 0.75

Chemical Structure| 455-14-1

[ 455-14-1 ]

4-(Trifluoromethyl)aniline

Similarity: 0.73

Trifluoromethyls

Chemical Structure| 97760-97-9

[ 97760-97-9 ]

2-Amino-5-iodobenzotrifluoride

Similarity: 0.91

Chemical Structure| 105202-02-6

[ 105202-02-6 ]

2-Iodo-5-(trifluoromethyl)aniline

Similarity: 0.89

Chemical Structure| 875306-20-0

[ 875306-20-0 ]

2-Bromo-6-iodo-4-(trifluoromethyl)aniline

Similarity: 0.81

Chemical Structure| 328-73-4

[ 328-73-4 ]

1-Iodo-3,5-bis(trifluoromethyl)benzene

Similarity: 0.75

Chemical Structure| 401-81-0

[ 401-81-0 ]

1-Iodo-3-(trifluoromethyl)benzene

Similarity: 0.75